The Medical and Surgical Practice of NaProTECHNOLOGY, 573-590, 2004
Chapter 43: Polycystic Ovarian Disease
Author affiliations
- Pope Paul VI Institute for the Study of Human Reproduction, Omaha, Nebraska. ROR
Abstract
PCOS (polycystic ovary syndrome), increasingly designated PMOS (polycystic metabolic ovary syndrome) to reflect its metabolic complexity, is far more prevalent than its classic presentation suggests, affecting roughly six percent of reproductive-age women and carrying systemic consequences well beyond fertility disruption. This chapter from the foundational NaProTECHNOLOGY textbook maps the hormonal architecture of the condition, its ovulatory defect patterns, its frequent co-occurrence with endometriosis, and the restorative surgical and cycle-tracking approaches developed at the Pope Paul VI Institute.
Topics
PCOS > Polycystic Ovary Syndrome > Epidemiology and PrevalencePCOS > PMOS Emerging Nomenclature > Metabolic ReframePCOS > Ovulatory Dysfunction > Defective Ovulatory EventsPCOS > Co-existing Conditions > Endometriosis OverlapPCOS > Metabolic Consequences > Insulin Resistance and Cardiovascular RiskNaProTECHNOLOGY > Creighton Model > PCOS Biomarker ChartingNaProTECHNOLOGY > Restorative Surgery > Ovarian Wedge Resection
Cite this article
Hilgers, T. W. (2004). Chapter 43: Polycystic Ovarian Disease. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 573-590.
Hilgers TW. Chapter 43: Polycystic Ovarian Disease. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:573-590.